ID

29269

Descripción

DA-EDOCH14-R in Poor-prognosis Diffuse Large B-cell Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT01066429

Link

https://clinicaltrials.gov/show/NCT01066429

Palabras clave

Versiones (1)
  1. 14/3/18 14/3/18 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

14 de marzo de 2018

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Diffuse Large B-Cell Lymphoma (DLBCL) NCT01066429

Inglés

Eligibility Diffuse Large B-Cell Lymphoma (DLBCL) NCT01066429

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
signing the informed consent.
Descripción

Informed Consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
histology: diffuse large b-cell lymphoma de novo (primary mediastinal b-cell lymphomas will be included provided that they have a mass greater than 7 cm in larger diameter) and follicular nhl grade 3b.
Descripción

Diffuse Large B-Cell Lymphoma de novo | Primary Mediastinal Large B-Cell Lymphoma Mass Diameter | Follicular Lymphoma Ann Arbor lymphoma staging system

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0079744
UMLS CUI [1,2]
C1515568
UMLS CUI [2,1]
C1292754
UMLS CUI [2,2]
C1306372
UMLS CUI [2,3]
C1301886
UMLS CUI [3,1]
C0024301
UMLS CUI [3,2]
C0432516
aaipi: 2-3.
Descripción

International Prognostic Index Adjusted Age

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1512894
UMLS CUI [1,2]
C3831006
age: between 18 and 70 years.
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
general condition (ecog/who): proper organic function, defined by: fevi ≥ 40%, serum creatinine < 150 µmol/l, serum bilirubin < 30 µmol/l, control of other medical conditions such as: infection, leukocytes ≥ 3.5 x 109/l and platelets ≥ 100 x 109/l (except if they are caused by lymphomatous infiltration of bone marrow or of the spleen).
Descripción

General finding of patient ECOG performance status | General finding of patient WHO performance status scale | Organ function | FEV1 | Creatinine measurement, serum | Serum total bilirubin measurement | Communicable Disease control | White Blood Cell Count procedure | Platelet Count measurement | Exception Lymphomatous infiltration Bone Marrow | Exception Lymphomatous infiltration Spleen

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0424449
UMLS CUI [1,2]
C1520224
UMLS CUI [2,1]
C0424449
UMLS CUI [2,2]
C1298650
UMLS CUI [3]
C0678852
UMLS CUI [4]
C0849974
UMLS CUI [5]
C0201976
UMLS CUI [6]
C1278039
UMLS CUI [7,1]
C0009450
UMLS CUI [7,2]
C0243148
UMLS CUI [8]
C0023508
UMLS CUI [9]
C0032181
UMLS CUI [10,1]
C1705847
UMLS CUI [10,2]
C2960101
UMLS CUI [10,3]
C0005953
UMLS CUI [11,1]
C1705847
UMLS CUI [11,2]
C2960101
UMLS CUI [11,3]
C0037993
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
hiv-positive.
Descripción

HIV Seropositivity

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0019699
pregnancy or breastfeeding.
Descripción

Pregnancy | Breast Feeding

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
serious disease compromising the performance of the therapeutic regimen.
Descripción

Disease Serious compromises Therapeutic procedure

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0205404
UMLS CUI [1,3]
C2945640
UMLS CUI [1,4]
C0087111
recent history of another malignant disease (except skin cancer different from melanoma or carcinoma in-situ of the cervix), prior radiotherapy or chemotherapy, history of indolent lymphoma.
Descripción

Malignant disease Other | Exception Skin carcinoma | Exception Carcinoma in situ of uterine cervix | Prior radiation therapy | Prior Chemotherapy | Indolent lymphoma

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0442867
UMLS CUI [1,2]
C0205394
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0699893
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0851140
UMLS CUI [4]
C0279134
UMLS CUI [5]
C1514457
UMLS CUI [6]
C1334170
cns infiltration at diagnosis.
Descripción

Central Nervous System Infiltration

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3714787
UMLS CUI [1,2]
C0332448
Volver a la parte superior de la página

Similar models

Eligibility Diffuse Large B-Cell Lymphoma (DLBCL) NCT01066429

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Informed Consent
Item
signing the informed consent.
boolean
C0021430 (UMLS CUI [1])
Diffuse Large B-Cell Lymphoma de novo | Primary Mediastinal Large B-Cell Lymphoma Mass Diameter | Follicular Lymphoma Ann Arbor lymphoma staging system
Item
histology: diffuse large b-cell lymphoma de novo (primary mediastinal b-cell lymphomas will be included provided that they have a mass greater than 7 cm in larger diameter) and follicular nhl grade 3b.
boolean
C0079744 (UMLS CUI [1,1])
C1515568 (UMLS CUI [1,2])
C1292754 (UMLS CUI [2,1])
C1306372 (UMLS CUI [2,2])
C1301886 (UMLS CUI [2,3])
C0024301 (UMLS CUI [3,1])
C0432516 (UMLS CUI [3,2])
International Prognostic Index Adjusted Age
Item
aaipi: 2-3.
boolean
C1512894 (UMLS CUI [1,1])
C3831006 (UMLS CUI [1,2])
Age
Item
age: between 18 and 70 years.
boolean
C0001779 (UMLS CUI [1])
General finding of patient ECOG performance status | General finding of patient WHO performance status scale | Organ function | FEV1 | Creatinine measurement, serum | Serum total bilirubin measurement | Communicable Disease control | White Blood Cell Count procedure | Platelet Count measurement | Exception Lymphomatous infiltration Bone Marrow | Exception Lymphomatous infiltration Spleen
Item
general condition (ecog/who): proper organic function, defined by: fevi ≥ 40%, serum creatinine < 150 µmol/l, serum bilirubin < 30 µmol/l, control of other medical conditions such as: infection, leukocytes ≥ 3.5 x 109/l and platelets ≥ 100 x 109/l (except if they are caused by lymphomatous infiltration of bone marrow or of the spleen).
boolean
C0424449 (UMLS CUI [1,1])
C1520224 (UMLS CUI [1,2])
C0424449 (UMLS CUI [2,1])
C1298650 (UMLS CUI [2,2])
C0678852 (UMLS CUI [3])
C0849974 (UMLS CUI [4])
C0201976 (UMLS CUI [5])
C1278039 (UMLS CUI [6])
C0009450 (UMLS CUI [7,1])
C0243148 (UMLS CUI [7,2])
C0023508 (UMLS CUI [8])
C0032181 (UMLS CUI [9])
C1705847 (UMLS CUI [10,1])
C2960101 (UMLS CUI [10,2])
C0005953 (UMLS CUI [10,3])
C1705847 (UMLS CUI [11,1])
C2960101 (UMLS CUI [11,2])
C0037993 (UMLS CUI [11,3])
Item Group
C0680251 (UMLS CUI)
HIV Seropositivity
Item
hiv-positive.
boolean
C0019699 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
pregnancy or breastfeeding.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Disease Serious compromises Therapeutic procedure
Item
serious disease compromising the performance of the therapeutic regimen.
boolean
C0012634 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C2945640 (UMLS CUI [1,3])
C0087111 (UMLS CUI [1,4])
Malignant disease Other | Exception Skin carcinoma | Exception Carcinoma in situ of uterine cervix | Prior radiation therapy | Prior Chemotherapy | Indolent lymphoma
Item
recent history of another malignant disease (except skin cancer different from melanoma or carcinoma in-situ of the cervix), prior radiotherapy or chemotherapy, history of indolent lymphoma.
boolean
C0442867 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0699893 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0851140 (UMLS CUI [3,2])
C0279134 (UMLS CUI [4])
C1514457 (UMLS CUI [5])
C1334170 (UMLS CUI [6])
Central Nervous System Infiltration
Item
cns infiltration at diagnosis.
boolean
C3714787 (UMLS CUI [1,1])
C0332448 (UMLS CUI [1,2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial